SHARE
COPY LINK

HEALTH

Switzerland set to extend coronavirus measures ‘until end of February’

Swiss authorities are set to meet on Wednesday to discuss extending the current coronavirus measures. According to Swiss media, they look set to be extended until the end of February.

Switzerland set to extend coronavirus measures 'until end of February'
A closed watch shop in Geneva during Switzerland's lockdown. Photo: FABRICE COFFRINI / AFP

Switzerland’s Federal Council is set to meet for the first time in 2021 on Wednesday. 

The first item on the agenda is to consider the status of Switzerland’s current coronavirus measures beyond their current end date of January 22nd. 

READ MORE: What are Switzerland's current coronavirus shutdown measures?

Several measures are set to be extended until the end of February, according to reports in Swiss media.

This includes the closure of fitness centres, restaurants and museums. 

Health Minister Alain Berset is in favour of extending the shutdown measures until the end of February – and wants to ensure that they remain the same in all cantons, reports Switzerland’s Tages Anzeiger.

Swiss tabloid Blick is also reporting that the existing measures – which it calls ‘lockdown light’ – are set to be extended until the end of February. 

One important change however would be that “role model cantons” – i.e. cantons with a lower infection rate – would no longer be granted an exception to the measures. 

As The Local Switzerland reported on Monday, several French-speaking cantons had been given an exception to the national measures due to lower R-Rates. 

This allowed them to avoid putting in place the federal measures – provided their R-rate stayed below 1. 

This exception was however rescinded as these infection rates climbed. 

20 Minutes reports that a range of stricter measures have been put to the cantons for consultation. 

This includes a Switzerland-wide closure of all non-essential shops, defined in the report as “shops that do not sell everyday goods”. 

In addition, stricter requirements for working from home along with renewed school closures have been suggested

 

 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Which medications in Switzerland are set to become more expensive?

The cost of medications in Switzerland is already quite a bit higher than elsewhere in Europe. And now certain drugs will become even pricier.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries. 

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023. 

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin. 

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland. 

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more  for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

SHOW COMMENTS